Big Picture Bio
AI-designed combination therapies for cancer and other complex diseases.
Big Picture Bio is a biotech & life sciences company based in London, GB. It has raised $2.92 million in disclosed funding. Its latest round was a Pre-seed of €2.55 million in September 2026.
Overview
No overview yet. It is written from sources once there are enough of them.
Funding
Total disclosed: $2.9M across 1 round. Computed only from sourced rounds.
| Date | Company | Amount | Stage | Lead | Other investors | Sector | Sources |
|---|---|---|---|---|---|---|---|
| €2.5M | Pre-seed | Kadmos Capital, Exceptional Ventures | Gloucester Ventures +1 | Biotech & Life Sciences | 1 |
- Big Picture Bio€2.5M
Led by Kadmos Capital, Exceptional Ventures · with Gloucester Ventures, +1
Investors
Questions and answers
What does Big Picture Bio do?
AI-designed combination therapies for cancer and other complex diseases.
How much has Big Picture Bio raised?
Big Picture Bio has raised $2.92 million in disclosed funding across 1 round tracked by OSH.
Who has invested in Big Picture Bio?
Investors in Big Picture Bio include Kadmos Capital, Exceptional Ventures, Gloucester Ventures, and John White.
When and where was Big Picture Bio founded?
Big Picture Bio and is based in London, GB.
Sources
- 1.London-based Big Picture Bio emerges from stealth with €2.55 million to develop AI-designed cancer drug combinations — EU-Startups, Sep 18, 2026